Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
En dos meses, baj de 84 a 75 kilos
E-112-2007-0), has been developed in the laboratories of Drs
Retatrutide (LY3437943) is a once-weekly injection that activates three different hormone receptors at the same time: GLP-1 (Glucagon-Like Peptide-1) receptor - controls blood sugar and appetite GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor - enhances insulin release and metabolism Glucagon receptor - increases energy expenditure and fat burning Think of it like this: Semaglutide (Ozempic) = Single agonist (GLP-1 only) Tirzepatide (Mounjaro) = Dual agonist (GLP-1 + GIP) Retatrutide = Triple agonist (GLP-1 + GIP + Glucagon) Each added receptor appears to amplify the benefits
Cardiac GLP-1R signaling pathways There is considerable overlap between pathways induced by the GLP-1R activation
These lab-made peptides can target specific cells and receptors in your body
US$ 27.40
US$ 29.90
US$ 26.96
US$ 29.33
US$ 28.48
US$ 23.58
US$ 27.44
